Analysis of the Global Infectious Disease Diagnostics Market

Analysis of the Global Infectious Disease Diagnostics Market

Molecular Methods Present Significant Opportunities

RELEASE DATE
23-Sep-2014
REGION
North America
Research Code: NE02-01-00-00-00
SKU: LS00126-NA-MR_16967
AvailableYesPDF Download

$3,950.00

Special Price $2,962.50 save 25 %

In stock
SKU
LS00126-NA-MR_16967

$3,950.00

$2,962.50save 25 %

DownloadLink
ENQUIRE NOW

Description

This deliverable provides research and analysis of the global infectious disease diagnostics market. It includes an in-depth analysis of revenue forecast by segment, drivers and restraints, and technology trends, along with the competitive factors and strategies, and key companies to watch. The global market is primarily driven by the high prevalence of these diseases and the growing demand for rapid diagnostic tests. Regional breakdowns are provided for three market segments: immunodiagnostics, molecular methods, and clinical microbiology. Regional breakdowns by disease also are provided. The base year for the study is 2013; the forecast period is from 2014 to 2018.

Table of Contents

Key Findings

Key Findings (continued)

Scope and Segmentation

Top Diseases by Region

Diseases and Available Solutions in the Global Market

Key Questions This Study Will Answer

Market Engineering Measurements

CEO’s Perspective

Key Companies to Watch

Executive Summary—3 Big Predictions

Market Background—Infectious Diseases

Disease Background—Sepsis

Disease Background—TB

Disease Background—MRSA

Disease Background—Hepatitis B and C

Disease Background—Hepatitis B and C (continued)

Disease Background—Hantavirus

Market Segmentation—Definitions

Market Segmentation

Healthcare Trends

Solutions Provided for Each Disease

New Market Opportunities

New Market Opportunities (continued)

New Market Opportunities (continued)

Merger, Acquisition, and Partnership Assessment

Merger, Acquisition, and Partnership Assessment (continued)

Merger, Acquisition, and Partnership Assessment (continued)

Market Engineering Measurements

Forecast Assumptions and Definitions

Revenue Forecast

Revenue Forecast Discussion

Percent Revenue Forecast by Region

Revenue Forecast by Region

Percent Revenue Forecast by Segment

Revenue Forecast by Segment

Revenue Forecast by Segment Discussion

Revenue Forecast by Segment Discussion (continued)

Revenue Forecast by Segment Discussion (continued)

Segment Lifecycle Analysis

Competitive Environment

Marketed Product Analysis—TB

Marketed Product Analysis—TB (continued)

Marketed Product Analysis—Sepsis

Marketed Product Analysis—MRSA

Marketed Product Analysis—Hepatitis B/C

Marketed Product Analysis—Hepatitis B/C (continued)

Top Competitors

Top Competitors (continued)

Top Competitors (continued)

Market Engineering Measurements

Revenue Forecast

Revenue Forecast by Disease

Revenue Forecast Discussion

Revenue Forecast by Segment

Revenue Forecast by Segment Discussion

Revenue Forecast by Segment Discussion (continued)

Revenue Forecast by Segment Discussion (continued)

US—Market Analysis

PESTLE Analysis

Market Impact of Top Trends

US—Market Share by Tier

US—Tier Analysis

US—Tier Analysis (continued)

US—Tier Analysis (continued)

Market Engineering Measurements

Revenue Forecast

Revenue Forecast by Disease

Revenue Forecast Discussion

Revenue Forecast by Segment

Revenue Forecast by Segment Discussion

Revenue Forecast by Segment Discussion (continued)

Revenue Forecast by Segment Discussion (continued)

PESTLE Analysis

Market Impact of Top Trends

Western Europe—Market Analysis

Western Europe—Market Share by Tier

Western Europe—Tier Analysis

Western Europe—Tier Analysis (continued)

Western Europe—Tier Analysis (continued)

Market Engineering Measurements

Revenue Forecast

Revenue Forecast Discussion

Revenue Forecast by Segment

Revenue Forecast by Segment Discussion

Revenue Forecast by Segment Discussion (continued)

Revenue Forecast by Segment Discussion (continued)

PESTLE Analysis

Market Impact of Top Trends

APAC & ROW—Market Analysis

APAC & ROW—Market Share by Tier

APAC & ROW—Tier Analysis

APAC & ROW—Tier Analysis

Reagena

Nanomix

Anagnostics GmbH

The Last Word—3 Big Predictions

The Last Word—Discussion

The Last Word—Discussion (continued)

The Last Word—Discussion (continued)

Legal Disclaimer

Drivers Explained

Drivers Explained (continued)

Restraints Explained

Restraints Explained (continued)

Restraints Explained (continued)

List of Other Companies—United States

List of Other Companies—Western Europe

List of Other Companies—APAC and ROW

Associated Multimedia

Associated Multimedia (continued)

Market Engineering Methodology

List of Exhibits

List of Exhibits (continued)

List of Exhibits (continued)

List of Exhibits (continued)

Related Research
This deliverable provides research and analysis of the global infectious disease diagnostics market. It includes an in-depth analysis of revenue forecast by segment, drivers and restraints, and technology trends, along with the competitive factors and strategies, and key companies to watch. The global market is primarily driven by the high prevalence of these diseases and the growing demand for rapid diagnostic tests. Regional breakdowns are provided for three market segments: immunodiagnostics, molecular methods, and clinical microbiology. Regional breakdowns by disease also are provided. The base year for the study is 2013; the forecast period is from 2014 to 2018.
More Information
No Index No
Podcast No
Author Aish Vivekanadan
WIP Number NE02-01-00-00-00
Is Prebook No